Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 27, 2026Score 5/30
$5.94−0.26 (-4.19%)
Close on Nov 18, 2026Market cap $91.83MP/E –Yield –
Satellos Bioscience operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$26.46M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.46M | – |
| FY2024 | Dec 31, 2024 | -$20.40M | – |
See a number that looks wrong?